Management Challenge:
The client’s portfolio of projects spans multiple therapy areas and are increasingly linked to complex therapies including gene or cell therapies, mRNA, etc. The company had a young workforce, with many of the team in their first or second role out of academia and this placed limits on their understanding of the strategic decision-making process linked to complex therapy development.
Project Setup
- The client identified the need for a subject matter expert (SME) to educate on development processes, decision making and organisational challenges for complex therapy development
- Conducted leadership team reviews to establish need for educational program in hybrid format.
Approach & Solution
- Sponsored by CCO and Strategy Director
- Researched gaps in client expertise and mindset
- Developed, in conjunction with leadership team, critical areas of development
- process to interrogate
- Recommended topics of tension that could be explored to challenge current
- company norms
- Provided examples of best practice from across the sector
- Created environment where curiosity and incremental improvements in
- processes are rewarded.
Benefits & Outcome
- Delivered outside / in perspective
- Increased knowledge of potential challenges in developing complex therapies
- Increased confidence to debate development options
- Follow up engagement to deliver webinar debate style presentation completed.
